Multiple Myeloma In Relapse clinical trials

Explore recruiting multiple myeloma in relapse clinical trials.

Recruiting multiple myeloma in relapse studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Multiple Myeloma In Relapse trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Anti-BCMA chimeric antigen receptor (CARTemis-1) T-lymphocyte therapy in the treatment of patients with multiple myeloma in relapse after allogeneic transplant: EGFR expression as a control mechanism of treatment-derived complications

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Multiple Myeloma In Relapse trials by city

Multiple Myeloma In Relapse in Toronto Multiple Myeloma In Relapse in Vancouver Multiple Myeloma In Relapse in Montreal Multiple Myeloma In Relapse in Calgary Multiple Myeloma In Relapse in Edmonton Multiple Myeloma In Relapse in Ottawa Multiple Myeloma In Relapse in Winnipeg Multiple Myeloma In Relapse in Quebec City Multiple Myeloma In Relapse in Hamilton Multiple Myeloma In Relapse in Kitchener Multiple Myeloma In Relapse in London Multiple Myeloma In Relapse in Halifax Multiple Myeloma In Relapse in New York Multiple Myeloma In Relapse in Los Angeles Multiple Myeloma In Relapse in Chicago Multiple Myeloma In Relapse in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease